Table 4 Agreement between HR and HER2 status from primary and metastatic samples
| Â | HR status* | HER2* | Â | |||
|---|---|---|---|---|---|---|
| Â | ER status | K (ASE) | PR status | K (ASE) | HER2 Status | K (ASE) |
Total (N) | 126 | Â | 123 | Â | 121 | Â |
Agreement, N (%) | Â | Â | Â | Â | Â | Â |
Yes | 98 (78) | 0.55 (0.074) | 86 (70) | 0.31 (0.083) | 101 (83) | 0.003 (0.019) |
No | 28 (22) | Â | Â | 37 (29) | Â | 20 (17) |
+ to - | 18 (14) | Â | Â | 30 (24) | Â | 20 (17) |
- to + | 10 (8) | Â | Â | 7 (6) | Â | N/A |